Trials / Conditions / Pemphigus Foliaceus
Pemphigus Foliaceus
7 registered clinical trials studyying Pemphigus Foliaceus — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in A NCT04598477 | argenx | Phase 3 |
| Completed | A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With NCT04598451 | argenx | Phase 3 |
| Unknown | Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus NCT04117529 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus NCT03334058 | argenx | Phase 2 |
| Terminated | Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus NCT03239470 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Terminated | A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) NCT03075904 | Alexion Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Recruiting | Autoimmune Blistering Diseases Study NCT02753777 | University of Pennsylvania | — |